Tag: entrepreneurs
-
Start-Up to Commercialize New Parkinson’s Treatment
Mavalon Therapeutics, a new company in the U.K., is being formed to bring a treatment to market that stops the progression of Parkinson’s disease.
-
Sweat Sensor Devised for Blood Glucose Measurement
A bioengineering lab at University of Texas in Dallas developed a miniature biosensor device that measures blood glucose levels from a person’s perspiration.
-
Worms-On-A-Chip Drug Screening System Designed
A system using live roundworms on a microfluidics chip and high-speed image analysis can quickly and simultaneously screen nearly 100 drug compounds.
-
Harvard Spin-Off to Sequence, Visualize RNA in Tissue
A new spin-off enterprise from Harvard University is commercializing technology that enables sequencing and imaging of genetic transcriptions of cells in their original tissue.
-
Spin-Off Companies to Develop Chronic Disease Therapies
Two new spin-off enterprises are being created to develop gut-based treatments for chronic diseases using technologies from synthetic biology company Intrexon Corporation.
-
Clinical Trial Testing Live Bacteria as Acne Treatment
A clinical trial is recruiting participants to test a product with live skin bacteria made by biotechnology company AOBiome as a treatment for adult acne.
-
Challenge Seeks Health Technology Start-Ups
A new competition is seeking start-up enterprises worldwide to pitch their ideas for solving health care issues with technology directly to life sciences industry leaders.
-
Computational Drug Discovery Company Launches
A new enterprise, Relay Therapeutics, is being formed for computer-driven discovery of new drugs based on the movements and interactions of protein molecules.
-
Nanoparticle Therapy Start-Up Gains $4M in Early Funds
A start-up enterprise developing treatments for autoimmune disorders using protein-laden nanoparticles is raising $4 million in its first venture funding round.
-
Chip Device Speeds Single Cell Analysis
A microfluidic, or lab-on-a-chip, device speeds the analysis of individual cells, which its developers show can be applied immediately to testing antibiotics.